We are happy to announce that, in June 2026, our GMP certificate was extended to include Investigational Medicinal Products (IMPs).
In addition to the batch release of registered medicinal products, we are now authorized to provide batch certification and release for IMPs used in clinical trials.
This expansion enables us to support clients throughout an even broader part of the product life cycle – from clinical development to commercial supply – with reliable GMP expertise.
👉 More about our GMP-services.
DREHM Pharma. Sharing Experience. 🌐
